(Press-News.org) LA JOLLA, Calif., March 25, 2014 — A team of scientists, led by Stuart Lipton, M.D., Ph.D., professor and director of the Neuroscience and Aging Research Center at Sanford-Burnham Medical Research Institute (Sanford-Burnham), recently discovered why cerebellar granule cell neurons in patients suffering from ataxia-telangiectasia (A-T) were unable to repair DNA damage and thus died.
A-T is a hereditary condition that begins early in childhood, and causes a gradual loss of certain nerve cells in the cerebellum of the brain. A-T occurs in about 1 in 40,000 births, with symptoms including severe loss of muscle control, dilated small blood vessels, repeated infections in the sinus and lungs, and it frequently leads to cancers such as lymphoma or leukemia. Today, thanks to improved treatment of infections and cancer, many patients live into their 30s or longer.
His study, with Nobuki Nakanishi, Ph.D., associate professor in Sanford-Burnham's Degenerative Disease Program, was published March 25 in The Journal of Neuroscience. The researchers used genetically engineered mice to show that myoctye-enhancer factor 2D (MEF2D), a transcription factor that turns on specific genes involved in cell survival, is activated after binding to a protein known as A-T mutated (ATM). When the ATM gene that codes for the ATM protein is mutated, thus causing A-T, ATM-MEF2D-survival signals in response to DNA damage are ineffective and may contribute to neurodegeneration.
"This is the first time that a signal that regulates MEF2D-dependent survival in response to DNA damage has been identified," said Lipton. "Knowing that ATM-mediated activation of MEF2D promotes survival in cerebellar neurons in response to DNA damage may provide a therapeutic opportunity for A-T. For example, if we can confirm that defects in the ATM-MEF2D signal contribute to A-T, we can search for molecules that enhance MEF2D activity to 'revive' the DNA repair system."
"As parents, we are excited that this research could lead to new ideas about how to slow the brain cell loss seen in our kids, improving their ability to walk, talk, and eat. This could lead to big improvements in their quality of life," said Brad Margus, voluntary president and founder of the A-T Children's Project.
In general, DNA repair systems are essential for cellular integrity and stability. DNA can be damaged in many ways, including UV rays, tobacco, and oxidative damage from byproducts of metabolism, such as free radicals. Inherited defects of DNA repair systems can lead to many types of cancer, dwarfism, growth and mental retardation, deafness—as well as A-T.
"Prior to this study, we knew that p53—a protein known as the guardian angel of the genome—was a target of ATM activation and contributes to the control and efficacy of DNA repair. Now, we have shown another pathway whereby MEF2D participates in DNA damage repair in the cerebellum. The fact that there is an abundance of MEF2D in the cerebellum, and that ATM mutations are associated with A-T, adds support to the proposed ATM-MEF2D dysfunction as a cause of A-T," said Lipton.
"Moving forward, we will be interested to see if this mechanism contributes to other rare hereditary diseases with defects in DNA repair."
INFORMATION:
In addition to his appointment at Sanford-Burnham, Dr. Lipton is a practicing neurologist at UC San Diego.
The study was supported by the Ataxia Telangiectasia Children's Project and National Institutes of Health grants RO1 EY05477, P01, HD29587, P30 ESO16738, and P30NSO76411.
About the A-T Children's Project
Established in the United States in 1993, the A-T Children's Project is a 501c3 nonprofit organization that raises funds to support and coordinate biomedical research projects, scientific conferences and a clinical center aimed at finding life-improving therapies and a cure for ataxia-telangiectasia (A-T). A-T is a rare, genetic disease that attacks children, causing progressive loss of muscle control, cancer, and immune system problems. For more information see: - http://www.atcp.org/About
About Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration and stem cells, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs 1,200 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at sanfordburnham.org.
Unravelling nerve-cell death in rare children's disease
2014-03-25
ELSE PRESS RELEASES FROM THIS DATE:
Brain differences in college-aged occasional drug users
2014-03-25
Researchers at the University of California, San Diego School of Medicine have discovered impaired neuronal activity in the parts of the brain associated with anticipatory functioning among occasional 18- to 24-year-old users of stimulant drugs, such as cocaine, amphetamines and prescription drugs such as Adderall.
The brain differences, detected using functional magnetic resonance imaging (fMRI), are believed to represent an internal hard wiring that may make some people more prone to drug addiction later in life.
Among the study's main implications is the possibility ...
Penn study: Distance from designated VA liver transplant center linked with greater risk of death
2014-03-25
(PHILADELPHIA) – Veterans with liver disease who live more than 100 miles from a Veterans Administration hospital that offers liver transplants are only half as likely to be placed on the liver transplant waitlist to receive a new organ compared to veterans who live closer to transplant centers, according to a new study from the Perelman School of Medicine of the University of Pennsylvania. The findings, which are published in the March 26 issue of JAMA, also reveal that the further liver disease patients live from these five transplant centers, the more likely they are ...
Treatment helps reduce risk of esophagus disorder progressing to cancer
2014-03-25
Among patients with the condition known as Barrett esophagus, treatment of abnormal cells with radiofrequency ablation (use of heat applied through an endoscope to destroy cells) resulted in a reduced risk of this condition progressing to cancer, according to a study in the March 26 issue of JAMA.
In the last 3 decades, the incidence of esophageal cancer has increased more rapidly that other cancers in the Western world. This type of cancer often originates from Barrett esophagus, a condition that involves abnormal changes in the cells of the lower portion of the esophagus, ...
Web-based alcohol screening program shows limited effect among university students
2014-03-25
Among university students in New Zealand, a web-based alcohol screening and brief intervention program produced a modest reduction in the amount of alcohol consumed per drinking episode but not in the frequency of drinking, overall amount consumed, or in related academic problems, according to a study in the March 26 issue of JAMA.
Unhealthy alcohol use is common among young people, including university students. Using an internet site to screening students for unhealthy alcohol use and intervene if appropriate has been suggested as an inexpensive means of reaching large ...
Effect of distance from transplant center on outcomes
2014-03-25
Among veterans meeting eligibility for liver transplantation, greater distance from a Veterans Affairs transplant center or any transplant center was associated with lower likelihood of being put on a waitlist or receiving a transplant, and a greater likelihood of death, according to a study in the March 26 issue of JAMA.
Centralization of specialized health care services is used to control costs, concentrate expertise, and minimize regional differences in quality of care. Although efficient, centralization may offset gains in care delivery by increasing the distance ...
Blood glucose measure appears to provide little benefit in predicting risk of CVD
2014-03-25
In a study that included nearly 300,000 adults without a known history of diabetes or cardiovascular disease (CVD), adding information about glycated hemoglobin (HbA1c), a measure of longer-term blood sugar control, to conventional CVD risk factors like smoking and cholesterol was associated with little improvement in the prediction of CVD risk, according to a study in the March 26 issue of JAMA.
Because higher glucose levels have been associated with higher CVD incidence, it has been proposed that information on blood sugar control might improve doctors' ability to ...
Study finds substantial decrease in use of cardiac imaging procedure
2014-03-25
There has been a sharp decline since 2006 in the use of nuclear myocardial perfusion imaging (MPI; an imaging procedure used to determine areas of the heart with decreased blood flow), a decrease that cannot be explained by an increase in other imaging methods, according to a study in the March 26 issue of JAMA.
Nuclear myocardial perfusion imaging accounted for much of the rapid growth in cardiac imaging that occurred from the 1990s through the middle 2000s. Edward J. McNulty, M.D., of Kaiser Permanente Medical Center, San Francisco, and colleagues conducted a study ...
Texas researcher: Peaches inhibit breast cancer metastasis in mice
2014-03-25
COLLEGE STATION – Lab tests at Texas A&M AgriLife Research have shown that treatments with peach extract inhibit breast cancer metastasis in mice.
AgriLife Research scientists say that the mixture of phenolic compounds present in the peach extract are responsible for the inhibition of metastasis, according to the study, which was this month published in the Journal of Nutritional Biochemistry.
"Cancer cells were implanted under the skin of mice with an aggressive type of breast cancer cells, the MDA-MB-435, and what we saw was an inhibition of a marker gene in the lungs ...
Robotic arm probes chemistry of 3-D objects by mass spectrometry
2014-03-25
VIDEO:
In early tests, the research team used a Kuka KR5 sixx R650 robot, seen in action here.
Click here for more information.
When life on Earth was first getting started, simple molecules bonded together into the precursors of modern genetic material. A catalyst would have been needed, but enzymes had not yet evolved. One theory is that the catalytic minerals on a meteorite's surface could have jump-started life's first chemical reactions. But scientists need a way to directly ...
JCI online ahead of print table of contents for March 25, 2014
2014-03-25
Epigenetic alterations disrupt intestinal T cell homeostasis
A precise balance between mature T cell subsets is important for intestinal homeostasis. Disruption of T cell populations underlies autoimmune colitis, including inflammatory bowel disease (IBD). Specific transcriptional programs are activated to determine the differentiation fate of naïve T cells; however, the role of epigenetic regulation in T cell maturation in the intestine is unclear. In this issue of the Journal of Clinical Investigation, Colby Zaph and colleagues from the University of British Columbia ...